Market Overview

The global enzymes market was valued at USD 13.97 Billion in 2024 and is projected to reach USD 21.9 Billion by 2033. It is expected to grow at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2033. The market growth is driven by rising demand for enzymes across industries including food, healthcare, and biofuels, along with increasing sustainability concerns and advancements in biotechnology. North America dominates the market with the largest share.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Enzymes Market Key Takeaways

• The global enzymes market size was valued at USD 13.97 Billion in 2024 with a CAGR of 5.3% during the forecast period 2025-2033.
• North America dominated the market with a share of over 36.8% in 2024.
• The healthcare and pharmaceutical sectors are key growth drivers due to their significant role in diagnostics, therapeutics, and drug development.
• Increasing consumer awareness towards sustainability and green alternatives is shaping industry demand.
• Biotechnology and genetic engineering advancements are fostering enzyme innovation and application.
• The food and beverage industry leads in enzyme consumption, driven by the demand for processing efficiency and clean-label products.
• IMARC Group’s report offers detailed segmentation analysis by type, source, reaction type, application, and region.

Sample Request Link: https://www.imarcgroup.com/enzymes-market/requestsample

Market Growth Factors

The global enzymes market is propelled by heightened demand across several industries. One major driver is the food and beverage (F&B) industry where enzymes are critical to processing efficiency, product innovation, and quality enhancement. The enzymes improve food texture, taste, and nutrition, and meet consumer demand for clean-label and natural ingredients. Additionally, the healthcare sector relies heavily on enzymes for diagnostics, therapeutics, and drug development. The use of proteases, lipases, and polymerases in synthesizing active pharmaceutical ingredients and biologics like monoclonal antibodies and vaccines is rising. Enzymes also facilitate enzyme replacement therapies for chronic diseases including Gaucher’s disease and cystic fibrosis.

Sustainability and environmental concerns significantly contribute to enzymes market growth. Enzymes convert traditional chemical processes into greener, eco-friendly alternatives that minimize harsh chemical use and waste production. With municipal solid waste generation forecasted by UNEP to increase from 2.1 billion tons in 2023 to 3.8 billion tons in 2050, the shift towards environmentally safe products and regulations enhances enzymes demand. Enzymes ensure compliance with environmental norms while maintaining product quality and process efficiency, further cementing their role in sustainable industrial applications.

Another critical growth factor is rapid progress in biotechnology and genetic engineering, enabling customization and engineering of enzymes for specialized industrial uses. According to ISAAA, genetically modified crops covered 191.7 million hectares in 2018, reflecting the broad acceptance of biotech advances. Engineered enzymes demonstrate higher stability, specificity, and activity, broadening their industrial applicability. Recombinant DNA technology facilitates scalable and cost-effective enzyme production, integrating enzymes into modern technological developments. This biotech intersection advances enzyme efficiency and fosters their adoption across sectors like agriculture, biofuels, and pharmaceuticals.

Market Segmentation

Analysis by Type:

• Protease
• Carbohydrase
• Lipase
• Polymerase and Nuclease
• Others

Carbohydrase accounted for the largest market segment in 2024 (~46.8%) due to its role in healthy food production, gluten-free products, and converting lignocellulosic biomass into biofuels. Recent enzyme engineering advancements may further improve carbohydrase performance.

Analysis by Source:

• Microorganisms
• Plants
• Animals

Microorganisms dominate the market with around 85.2% share in 2024, driven by demand in agriculture, F&B, waste management, and renewable energy sectors. Biotechnology advances enable expanded applications like biopesticides and probiotics.

Analysis by Reaction Type:

• Hydrolase
• Oxidoreductase
• Transferase
• Lyase
• Others

Hydrolases are the leading segment owing to their role in hydrolyzing substrates across food, detergent, and pharmaceutical industries. Engineered hydrolases offer increased efficiency and specificity, expanding their application scope.

Analysis by Application:

• Food and Beverages
• Household Care
• Bioenergy
• Pharmaceutical and Biotechnology
• Feed
• Others

The food and beverage segment held approximately 78.9% market share in 2024. Enzymes enhance product quality, flavor, and nutrition, reduce processing time and energy use, and support clean label trends. Personalized nutrition and functional foods also stimulate enzyme demand.

Regional Insights

North America leads the enzymes market with over 36.8% share in 2024. This dominance is attributed to a strong industrial base demanding enzymes in sectors such as food and beverages, pharmaceuticals, and biofuels. The region benefits from consumer awareness of sustainability, stringent environmental regulations, and biotechnology-driven enzyme innovations, accelerating market growth. The booming biopharma industry further strengthens enzyme demand in development and manufacturing.

Recent Developments & News

• September 2024: Ligo Biosciences advanced deep-learning enzyme design models to reduce chemical manufacturing costs, accelerating enzyme design from years to days.
• August 2024: Twist Bioscience Corporation and bitBiome Inc. launched a Transaminase Enzyme Screening Kit with 48 curated enzymes for pharmaceutical applications.
• July 2024: EnPlusOne Biosciences synthesized the antisense strand of the siRNA drug Leqvio® (inclisiran), marking progress in RNA therapeutics.
• May 2024: Fermbox Bio introduced EN3ZYME, improving agricultural residue conversion for 2G ethanol and precision fermentation.
• July 2023: Codexis, Inc. refocused on its Enzyme-Catalyzed Oligonucleotide (ECO) platform, streamlined operations, and reduced its workforce by 25%.

Key Players

• Advanced Enzyme Technologies Limited
• Amano Enzyme Inc.
• Associated British Foods plc
• Aumgene Biosciences
• BASF SE
• Chr. Hansen Holding A/S
• Codexis Inc.
• DuPont de Nemours Inc.
• Koninklijke DSM N.V.
• Novozymes A/S
• Novus International Inc. (Mitsui & Co. Ltd.)
• Thermo Fisher Scientific Inc.

Customization Note

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request for customization: https://www.imarcgroup.com/request?type=report&id=5600&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302